About Company
As of May 12, 2000, The Liposome Company, Inc. was acquired by Elan Corp. plc. The Liposome Company, Inc. is engaged in the discovery, development, manufacturing, and marketing of proprietary lipid and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. Its products include drug delivery vehicles and pharmaceuticals utilizing modulated cell signaling and bioactive lipids. The company is based in Princeton, New Jersey.
